Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Celldex CLDX Operational Review Q4 2025 Earnings Underperform CVRx CVRX Stock Fundamentals Smart Money Exits 20260415 FATN FatPipe Inc posts 88 percent Q1 2026 year over year revenue decline shares rise modestly KraneShares CSI China Internet ETF KWEB Contrarian Opportunity Emerges as Chinas Economic Recovery Gains Traction Is Rein Therapeutics RNTX stock gaining strength Momentum Building 20260420 Is Theriva Biologics TOVX stock breaking out today Investors Pile In 20260420 Why Sonoco SON deserves a deeper look right now 114 20260511 What ORIX IXs 097 Decline Means for Investors 20260515 US USEG Climbs 230 Resistance at 101 in Focus 20260515 Malaysias Q1 GDP Growth Slows to 54 as Cost Pressures Mount Koninklijke PHG Q1 2026 Earnings EPS 023 Beats Estimates Inflation Accelerates as Conflict in Iran Disrupts Global Markets Inflation Rate Projected to Reach 6 in Q2 as Pressures Persist NATO to Spend Hundreds of Billions on Defense as Trump Pledges 5000 Troops to Poland Rutte Walmart Shares Plunge in Largest Daily Decline in Four Years Michael Burry Warns SECs CryptoStyle Trading Plan Could Spell Trouble for Investors US Productivity Growth Decelerates in Q4 as Labor Costs Rise SAP Unveils Vision for Next Era of Business AI Jamie Dimon Signals Potential Challenges for JPMorgan Bankers Amid Economic Uncertainty PRTS Q1 2026 Earnings EPS Surprises with 4885 Beat Stock Falls 392 HRI Q1 2026 Earnings Strong EPS Beat Surprises Market LMT Q1 2026 Earnings Earnings Miss Stock Rises Amid Defense Sector Optimism SITM Q1 2026 Earnings EPS Soars Past Consensus by 22 Stock Declines Marginally TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed CIMP Q1 2026 Earnings EPS Beats Estimates as Mortgage REIT Maintains Stable Performance Neuphoria Therapeutics NEUP Soars 7 Key Levels to Watch After Bullish Breakout Pentair PNR Slips 173 as Stock Tests Key Support Levels InMode INMD Pushes Higher Testing Resistance After a 16 Gain Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance Ziff Davis ZD Hovers Near Support as Consolidation Persists